1. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer’s Disease Continuum
- Author
-
Julie Pham, Bruce L. Miller, Amelia Strom, Taylor J. Mellinger, William J. Jagust, Suzanne L. Baker, Renaud La Joie, David N Soleimani-Meigooni, Leonardo Iaccarino, Howard J. Rosen, Lauren Edwards, Gil D. Rabinovici, Mustafa Janabi, Daniel R. Schonhaut, and Rik Ossenkoppele
- Subjects
Male ,Aging ,Pathology ,Disease ,Neurodegenerative ,Neuropsychological Tests ,Alzheimer's Disease ,Pathogenesis ,Amyloid beta-Protein Precursor ,80 and over ,2.1 Biological and endogenous factors ,Psychology ,Medicine ,tau ,Aetiology ,Gray Matter ,Pathology, Molecular ,Cognitive impairment ,Aged, 80 and over ,Molecular pathology ,Neurodegeneration ,neurodegeneration ,amyloid ,Experimental Psychology ,Neurodegenerative Diseases ,Middle Aged ,Magnetic Resonance Imaging ,Neurological ,Biomedical Imaging ,Cognitive Sciences ,Original Article ,Female ,spatial extent ,medicine.medical_specialty ,Amyloid ,Cognitive Neuroscience ,tau Proteins ,Cellular and Molecular Neuroscience ,topography ,Clinical Research ,Alzheimer Disease ,mental disorders ,Acquired Cognitive Impairment ,Humans ,Dementia ,Cognitive Dysfunction ,Aged ,business.industry ,Neurosciences ,Molecular ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,medicine.disease ,Brain Disorders ,Positron-Emission Tomography ,business ,Spatial extent - Abstract
A deeper understanding of the spatial relationships of β-amyloid (Aβ), tau, and neurodegeneration in Alzheimer’s disease (AD) could provide insight into pathogenesis and clinical trial design. We included 81 amyloid-positive patients (age 64.4 ± 9.5) diagnosed with AD dementia or mild cognitive impairment due to AD and available 11C-PiB (PIB), 18F-Flortaucipir (FTP),18F-FDG-PET, and 3T-MRI, and 31 amyloid-positive, cognitively normal participants (age 77.3 ± 6.5, no FDG-PET). W-score voxel-wise deviation maps were created and binarized for each imaging-modality (W > 1.64, P tau > neurodegeneration was the most frequent hierarchy for both groups (79–77%, respectively), followed by tau > amyloid > neurodegeneration (13–10%) and amyloid > neurodegeneration > tau (6–13%). For symptomatic participants, most abnormal voxels were PIB+/FTP+/ND− (median 35%), and the great majority of ND+ voxels (91%) colocalized with molecular pathology. Amyloid spatially exceeded tau and neurodegeneration, with individual heterogeneities. Molecular pathology and neurodegeneration showed a progressive overlap along AD course, indicating shared vulnerabilities or synergistic toxic mechanisms.
- Published
- 2020
- Full Text
- View/download PDF